Michel Vounatsos vs Kevin Gorman

Michel Vounatsos

CEO of Biogen

BIO: Mr. Michel Vounatsos has been the Chief Executive Officer of Biogen Inc. since January 6, 2017. Mr. Vounatsos served as the Chief Commercial Officer and Executive Vice President of Biogen Inc. since April 18, 2016 until December 2016. He is a sophisticated global business leader who has a track record of commercial success and creativity. He joined Biogen after a 20 year career at Merck, where he various positions including served as president, Primary Care Business Line and Merck Customer Centricity. Prior to this role, he held leadership positions at Merck across Europe and in China. He has been Director of Biogen Inc. since January 6, 2017. Mr. Vounatsos attended the Universite Victor Segalen, Bordeaux II, in France, receiving his C.S.C.T. certificate in Medicine. He received his M.B.A. from the HEC School of Management in Paris.

Kevin Gorman

CEO of Neurocrine Biosciences

BIO: Dr. Kevin C. Gorman, Ph.D., is Chief Executive Officer of Neurocrine Biosciences, Inc. Dr. Gorman served as Executive Vice President of Neurocrine Biosciences, Inc. since January 2006 until January 2008 and also served as its Chief Operating Officer since September 2006 until January 2008 and President from January 2008 to January 09, 2017. He served as Senior Vice President for Business Development of Neurocrine Biosciences, Inc. from January 2006 to September 2006 and its Chief Business Officer since January 2006. He has been employed with Neurocrine Biosciences, Inc. since 1993. From 1990 to 1993, Dr. Gorman was a Principal of Avalon Medical Partners, LP where he was responsible for the early stage founding of Avalon Medical Partners, LP and several other biotechnology companies such as Onyx Pharmaceuticals, Metra Biosystems, IDUN and ARIAD Pharmaceuticals. He has been a Director of Neurocrine Biosciences Inc. since January 2008 and Xencor, Inc. since April 14, 2017. Dr. Gorman received his Ph.D. degree in Immunology and M.B.A. in Finance from the University of California, Los Angeles and did further Post-Doctoral Training at The Rockefeller University.